SUSD2+ cancer-associated fibroblasts in gastric cancer mediate the effect of immunosuppression and predict overall survival and the effectiveness of neoadjuvant immunotherapy
Gastric Cancer · 2025
DOI: 10.1007/s10120-024-01572-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastric Cancer, 2025. Verfasst von Rishun Su und 15 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Cancer-Associated Fibroblasts, Neoadjuvant Therapy, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Guangdong Provincial Key Laboratory of Digestive Cancer Research, Sanming Project of Medicine in Shenzen Municipality, National Key Clinical Specialty Discipline Construction Program of China.
Abstract (Originalsprache)
BACKGROUND: The expression patterns and functions of Sushi Domain Containing 2 (SUSD2) differ among various malignancies. This research aims to investigate the expression of SUSD2 and the role of the SUSD2+ cancer-associated fibroblasts (CAFs) for immunotherapy in gastric cancer. METHODS: The expression of SUSD2 and specific markers (CD4, CD8, PD-1, TIGIT, TIM-3 and CD163) was determined using immunohistochemistry and multiplex immunofluorescence (mIHC) on paraffin sections. Flow cytometry and western blot were used to assess the expression of SUSD2 in fibroblasts from fresh samples. Also, analysis of single-cell and bulk RNA sequencing was employed to confirm the presence and characterize the function of SUSD2+ CAFs. The predictive power of indicators for neoadjuvant immunotherapy was evaluated via ROC curve analysis. Animal experiment was employed to validate the immunosuppressive effect of SUSD2+ CAFs. RESULTS: SUSD2 is mainly expressed on fibroblasts within the tumors and the high infiltration of SUSD2+ CAFs went together with a poor survival and a more advanced tumor stage. Significantly, the joint use of SUSD2+ CAFs and CD8+ T cells demonstrated a remarkable ability to predict the efficacy of neoadjuvant immunotherapy superior to PD-L1 combined positive score. High SUSD2+ CAFs was correlated with resistance to immunotherapy as well as low CD8+ T infiltration and high exhausted T cell infiltration. CONCLUSIONS: We have identified a novel subset of CAFs that could predict the survival and response to neoadjuvant immunotherapy of patients. The SUSD2+ CAFs have the potential to serve as a predictive biomarker and a promising target for immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.
- Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.
- Laboratory of Physiological Pathology, Nippon Veterinary and Life Science University, Tokyo, Japan.
- Department of Diagnostic Pathology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
- Department of Clinical Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Hoshi University, Tokyo, Japan.
- Hepatic-Biliary-Pancreatic Surgery, The Second People's Hospital of Foshan, Foshan, Guangdong Province, China.
ORCID-Profile: Songcheng Yin
Förderung
- Guangdong Provincial Key Laboratory of Digestive Cancer Research
- Sanming Project of Medicine in Shenzen Municipality
- National Key Clinical Specialty Discipline Construction Program of China
- Shenzhen Sustainable Project
- Guangdong-Hong Kong-Macau University Joint Laboratory of Digestive Cancer Research
- Natural Science Foundation of Shenzhen
- National Natural Science Foundation of China
- Shenzhen excellent Science and Technology Innovation Talent training Project
Zitieren
APA
Su, R., Sun, X., Luo, Y., Gu, L., Wang, F., Dong, A., Yamamoto, M., Tsukamoto, T., Nomura, S., Zhao, Z., Dai, C., Deng, G., Zhuang, B., He, Y., Zhang, C., & Yin, S. (2025). SUSD2+ cancer-associated fibroblasts in gastric cancer mediate the effect of immunosuppression and predict overall survival and the effectiveness of neoadjuvant immunotherapy. Gastric Cancer. https://doi.org/10.1007/s10120-024-01572-9
Vancouver
Su R, Sun X, Luo Y, Gu L, Wang F, Dong A, et al. SUSD2+ cancer-associated fibroblasts in gastric cancer mediate the effect of immunosuppression and predict overall survival and the effectiveness of neoadjuvant immunotherapy. Gastric Cancer. 2025. doi:10.1007/s10120-024-01572-9
BibTeX
@article{Su2025,
author = {Su, Rishun and Sun, Xuezeng and Luo, Yusheng and Gu, Liang and Wang, Fulin and Dong, Aoran and Yamamoto, Masami and Tsukamoto, Tetsuya and Nomura, Sachiyo and Zhao, Zhenzhen and Dai, Chen and Deng, Guofei and Zhuang, Baoding and He, Yulong and Zhang, Changhua and Yin, Songcheng},
title = {SUSD2+ cancer-associated fibroblasts in gastric cancer mediate the effect of immunosuppression and predict overall survival and the effectiveness of neoadjuvant immunotherapy},
journal = {Gastric Cancer},
year = {2025},
doi = {10.1007/s10120-024-01572-9}
}
EUVIMED